Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR
Authors:
- 13 January 2022
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 28 (1) , 27-34
Abstract
Proviral load (PVL) is one of the determining factors for the pathogenesis and clinical progression of the human T-lymphotropic virus type I (HTLV-1) infection. In the present study, we optimized a sensitive multiplex real-time PCR for the simultaneous detection and quantification of HTLV-1 proviral load and beta-globin gene as endogenous control. The values obtained for HTLV-1 PVL were used to monitor the clinical evolution in HTLV-1-infected individuals. A vector containing cloned DNA targets of the real-time PCR for the beta-globin gene and the HTLV-1pol region was constructed. For the reaction validation, we compared the amplification efficiency of the constructed vector and MT-2 cell line containing HTLV-1. The analytical sensitivity of the reaction was evaluated by the application of a standard curve with a high order of magnitude. PVL assay was evaluated on DNA samples of HTLV-1 seropositive individuals. The construct showed adequate amplification for the beta-globin and HTLV-1 pol genes when evaluated as multiplex real-time PCR (slope = 3.23/3.26, Y-intercept = 40.18/40.73, correlation coefficient r2 = 0.99/0.99, and efficiency = 103.98/102.78, respectively). The quantification of PVL using the MT-2 cell line was equivalent to the data obtained using the plasmidial curve (2.5 copies per cell). In HTLV-1-associatedmyelopathy/tropical spastic paraparesis patients, PVL was significantly higher (21315 ± 2154 copies/105 PBMC) compared to asymptomatic individuals (1253 ± 691 copies/105 PBMC). The obtained results indicate that the optimized HTLV-1 PVL assay using plasmidial curve can be applied for monitoring and follow-up of the progression of HTLV-1 disease. The use of a unique reference plasmid for both HTLV-1 and endogenous gene allows a robust and effective quantification of HTLV-1 PVL. In addition, the developed multiplex real-time PCR assay was efficient to be used as a tool to monitor HTLV-1-infected individuals.Keywords
Funding Information
- Financiadora de Estudos e Projetos (1387/10)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08135-2)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (465539/2014-9)
This publication has 20 references indexed in Scilit:
- Validation of a quantitative real-time PCR assay for HTLV-1 proviral load in peripheral blood mononuclear cellsJournal of Virological Methods, 2013
- Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole bloodJournal of Clinical Virology, 2012
- Monitoring the HTLV‐1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV‐associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk diseaseJournal of Medical Virology, 2012
- Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated MyelopathyPLOS Pathogens, 2012
- Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: Addressing the issue of indeterminate HTLV resultsJournal of Clinical Virology, 2011
- Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in JapanBlood, 2010
- Development and Validation of a Multiplex Real-Time PCR Assay for Simultaneous Genotyping and Human T-Lymphotropic Virus Type 1, 2, and 3 Proviral Load DeterminationJournal of Clinical Microbiology, 2009
- Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistryJournal of Clinical Virology, 2004
- Real-Time Polymerase Chain Reaction Assay for Cell-Associated HTLV Type I DNA Viral LoadAIDS Research and Human Retroviruses, 2000
- Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathyJournal of Neuroimmunology, 1993